Diabetic Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Diabetic Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: 12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study [Phase 2, Phase 3]
Clinical trial update reporting 12-month efficacy and safety results of Diepalrestat in adults with diabetic peripheral neuropathy from a pl…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy [NA]
A completed clinical trial assessed the efficacy of platelet-rich plasma injections for diabetic peripheral neuropathy. The trial was sponso…
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy [NA]
Completed clinical trial studying Mindfulness Based Stress Reduction in patients with Painful Diabetic Peripheral Neuropathy has an update.
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain [NA]
This update reports the termination of a University of Michigan trial on MR imaging of neurotransmitters in chronic pain. The study spanned …
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN). [Phase 2]
This update reports completion of a Phase 2 study evaluating RWJ-333369 (Carsibamate) for the treatment of diabetic peripheral neuropathy, f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-12Clinical Trial Update: Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy [NA]
A completed clinical trial update discusses balancing treatment outcomes and the medication burden for patients with symptomatic diabetic pe…
-
CLINICAL_TRIALS research · 2017-11-29Clinical Trial Update: The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy [NA]
This clinical trial update examines how a clinical pharmacist can support lifestyle modification in people with diabetes mellitus type 2 and…
-
FDA approval · 2017-10-11FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)
FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients . [NA]
This completed clinical trial assessed the effects of mesenchymal stem cell transfusion in patients with diabetic peripheral neuropathy; res…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN) [NA]
This document provides an update on the completed GATE-PDN trial evaluating group acupuncture for painful diabetic neuropathy.
-
FDA approval · 2017-05-18FDA Approved: DULOXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for duloxetine, enabling the marketing of a generic duloxetine product.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Efficacy & Safety Study of Nonracemic Methadone for the Relief of Chronic Peripheral Neuropathic Pain [Phase 2]
A Phase 2 efficacy and safety trial of nonracemic methadone for diabetic peripheral neuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: A Study to Evaluate PEMF Therapy on Experimentally Inducted Pain in Subjects With Painful Peripheral Diabetic Neuropathy [NA]
This ClinicalTrials.gov entry reports the completion and results posting of a study evaluating pulsed electromagnetic field (PEMF) therapy f…
-
CLINICAL_TRIALS withdrawal · 2017-02-10Clinical Trial Update: Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP) [Phase 4]
A Phase 4 trial evaluating ranolazine for diabetic peripheral neuropathic pain has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating the efficacy of ACE-inhibition on autonomic and peripheral neuropathy in patients with diabetes mellitus has comple…
-
FDA approval · 2017-01-06FDA Approved: DULOXETINE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA 208706) for duloxetine from Quallent Pharmaceuticals Health LLC, establishing a generic version o…
-
FDA approval · 2016-12-22FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Division of Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy [Phase 3]
Phase 3 clinical trial update on pregabalin for walking-related pain in patients with diabetic peripheral neuropathy; the study has complete…
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability [Phase 2]
This Phase 2 trial evaluated safety, tolerability and preliminary efficacy of AZD5213 in combination with pregabalin in adults with painful …
-
FDA approval · 2016-09-30FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Tapentadol hydrochloride submitted by Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients [Phase 2]
Phase 2 clinical trial update on NRD135S.E1 for diabetic peripheral neuropathy with neuropathic pain. The study status is COMPLETED.
-
CLINICAL_TRIALS research · 2016-09-07Clinical Trial Update: Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study
A completed prospective study evaluating how common peripheral neuropathy is among children and adolescents with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy [Phase 2]
A Phase 2 clinical trial evaluating TAK-583 for diabetic peripheral neuropathy has completed, reporting efficacy and safety results.
-
CLINICAL_TRIALS research · 2016-01-18Clinical Trial Update: The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) [NA]
This Clinical Trial Update describes the ongoing evaluation of Metanx for potential nutritional benefits in patients with diabetic periphera…
-
FDA approval · 2015-12-22FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting app…